Another early investigation published in the European Journal of Endocrinology documented that, unlike older GH-releasing peptides, such as GHRP-2 or GHRP-6, ipamorelins GH stimulation is highly selective and does not significantly increase cortisol or prolactin levels, suggesting a cleaner hormonal profile with fewer off-target endocrine effects compared to earlier secretagogues
and acute, subacute, and chronic) shows a definitive rescue of disabled neuromuscular junctions (both phase I and phase II) and counteracts failure of nerve-to-muscle transmission [81]
2017;25:1334e13474
Washington, DC: VeriMed Healthcare Network
F., Arduini, A., Di, Liberato L., and Bonomini, M